Hardman & Co Research: Oxford BioMedica (OXB): Gene-therapy for Parkinson's: clinical progression



Hardman Co Research


Hardman Co Research: Oxford BioMedica (OXB): Gene-therapy for Parkinson's: clinical progression



14-Jun-2018 / 09:50 GMT/BST




Hardman Co Research: Gene-therapy for Parkinson's: clinical......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - 5 days ago
Share |